Written consent for participation in the clinical trial
Age 18 to 45 years Irregular menstruation (> 35 days) or secondary amenorrhea> 3 months

NCT03325023_inc_T2
Person
Age
NCT03325023_inc_T3
Value
18 to 45 years
NCT03325023_inc_T4
Condition
Irregular menstruation
NCT03325023_inc_T7
Value
> 35 days
NCT03325023_inc_T8
Condition
secondary amenorrhea
NCT03325023_inc_T9
Temporal
> 3 months